Skip to main content
SpringerLink
Log in

Epilepsy in 2017

Precision medicine drives epilepsy classification and therapy

  • Year in Review
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

2017 saw the publication of new classifications for epilepsy and seizure types, which emphasize the importance of understanding the underlying disease mechanisms. This aetiology-based approach is already beginning to inform developments in therapies and trial design in the epilepsies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Scheffer, I. E. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58, 512–521 (2017).

    Article  Google Scholar 

  2. Fisher, R. S. et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia 58, 522–530 (2017).

    Article  Google Scholar 

  3. Fisher, R. S. et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia 58, 531–542 (2017).

    Article  Google Scholar 

  4. [No authors listed]. Proposal for revised classification for epilepsies and epileptic syndromes. Epilepsia 30, 389–399 (1989).

  5. Devinsky, O. et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label intervention trial. Lancet Neurol. 15, 270–278 (2016).

    Article  CAS  Google Scholar 

  6. Devinsky, O. et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N. Engl. J. Med. 376, 2011–2020 (2017).

    Article  CAS  Google Scholar 

  7. Wu, Y. W. et al. Incidence of Dravet syndrome in a US population. Pediatrics 136, e1310–e1315 (2015).

    Article  Google Scholar 

  8. Dwivedi, R. et al. Surgery for drug-resistant epilepsy in children. N. Engl. J. Med. 377, 1639–1647 (2017).

    Article  Google Scholar 

  9. Kim, D. W. et al. Surgical treatment of non-lesional neocortical epilepsy: long-term longitudinal study. JAMA Neurol, 74, 324–331 (2017).

    Article  Google Scholar 

  10. O'Callaghan, F. J. et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 16, 33–42 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sameer M. Zuberi and Andreas Brunklaus are at the Royal Hospital for Children and School of Medicine, University of Glasgow, 1345 Govan Road, Glasgow G51 4TF, UK.,

    Sameer M. Zuberi & Andreas Brunklaus

Authors
  1. Sameer M. Zuberi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Brunklaus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sameer M. Zuberi.

Ethics declarations

Competing interests

S.M.Z. has received honoraria for educational activities and advisory boards from GW Pharma, paid to his institution's charitable account. He was Chair of the International League Against Epilepsy Commission for Classification and Terminology from 2013–2017. A.B. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuberi, S., Brunklaus, A. Precision medicine drives epilepsy classification and therapy. Nat Rev Neurol 14, 67–68 (2018). https://doi.org/10.1038/nrneurol.2017.190

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2017.190

  • Springer Nature Limited

This article is cited by

Search

Navigation